Injectable Contraceptives Market to Reach USD 6.9 Billion by 2032, Growing at 7.1% CAGR

CHICAGO - Oct. 22, 2025 - PRLog -- A news published at Globenewswire on industry forecast for the global Injectable Contraceptives Market, reveals strong growth prospects driven by increased awareness of family planning, expanding access in emerging markets, and innovation in long-acting contraceptive formulations.

Injectable Contraceptives Market Statistics

• Market size in 2022: USD 3.5 Billion
• Projected market size by 2032: USD 6.9 Billion
• Compound Annual Growth Rate (CAGR) from 2023 to 2032: 7.1%
• Regional leadership in 2022: North America held around 52% of market share
• Fastest single‐region growth: Asia-Pacific region expected to record a CAGR of approximately 7.5%
• By type: Progesterone-only injectables captured over 64% share in 2022
• By duration of action: Short-acting injectables accounted for more than 58% of revenue in 2022

Injectable Contraceptives Market Overview

The Injectable Contraceptives Market encompasses hormonal birth-control injections, typically administered every one to three months, offering a highly effective alternative to daily pills or implants. These injectables usually feature synthetic progestin alone or in combination with estrogen and are widely used for reversible contraception.

The global market is set for strong expansion from its 2022 base, approaching nearly USD 6.9 billion by 2032. Rising women's reproductive health awareness, better access to contraception in emerging economies, and larger volumes of family-planning initiatives are the key levers driving growth.

Download Full Report: https://h1.nu/1dcbG

Injectable Contraceptives Market Growth Drivers & Trends

• Increasing demand for convenience and discreet usage: Injectable contraceptives offer long-acting protection without daily adherence, making them highly appealing.
• Expanding reach in emerging markets: Governments and non-profits are scaling access and distribution in low- and middle-income regions, supporting broader uptake.
• Innovation in formulation technology: Newer options with lower side effects, longer duration, and simplified logistics are attracting wider acceptance.

Injectable Contraceptives Market Regional & Competitive Landscape

North America dominated the Injectable Contraceptives market in 2022, holding roughly half of global value, thanks to strong healthcare infrastructure, high contraceptive awareness, and advanced distribution networks. Meanwhile, the Asia–Pacific region is expected to deliver the fastest growth through 2032, as expanding healthcare access, rising disposable incomes and growing female population cohorts drive demand.

In terms of product type, the progesterone-only injectable segment leads, reflecting its preferred usage profile given efficacy and hormone-management advantages. Short-acting formulations dominate over longer-acting versions in revenue share, although newer longer-acting designs are gaining momentum.

Read Full News at Globenewswire: https://www.globenewswire.com/news-release/2023/09/27/2750612/0/en/Injectable-Contraceptives-Market-is-anticipated-to-grow-at-a-CAGR-of-7-1-reaching-a-valuation-of-USD-6-9-billion-by-2032.html